Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

書誌詳細
第一著者:	Monayem, Kazi Fahim
その他の著者:	Momtaz, Tanisha
フォーマット:	学位論文
言語:	English
出版事項:	Brac University 2024
主題:	Hepatocellular carcinoma Lenvatinib Sorafenib Demographic analysis Clinical decision making Randomized controlled trials Progression-free survival Liver > Cancer > Treatment. Cancer > Molecular aspects.
オンライン･アクセス:	http://hdl.handle.net/10361/23930

類似資料

Elucidating the functional roles of bidirectionally transcribed genes in immunobiology of cancers
著者:: Ahmad, Sheikh Shafin
出版事項: (2021)

Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
著者:: Shawn, Ibna Hasan
出版事項: (2024)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
著者:: Shobnam, Sohana
出版事項: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
著者:: Paul, Pulock
出版事項: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
著者:: Hasan, Amit
出版事項: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
著者:: Hoque, Ismoth Ara
出版事項: (2024)

Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
著者:: Raju, Md. Ismail
出版事項: (2022)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
著者:: Rahman, Tasnim
出版事項: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
著者:: Hasan, Sakib
出版事項: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
著者:: Mirza, Maisa Tasnim
出版事項: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Karim, Samia Binte
出版事項: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
著者:: Bristy, Israt Zerin
出版事項: (2021)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
著者:: Oishy, Jannatun Noor
出版事項: (2024)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
著者:: Rahman, Sanjida
出版事項: (2024)

Anticancer activity of alangium salvifolium flower in ehrlich ascites carcinoma bearing mice
著者:: Zahan, Ronok, 等
出版事項: (2016)

Exploring the use of Ingenol Mebutate to prevent non-melanoma skin cancer: A review
著者:: Haque, Fariha
出版事項: (2023)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
著者:: Abir, Shifaty Nur
出版事項: (2024)

In vitro antioxidant and anti-neoplastic activities of Ocimum sanctum leaves in Ehrlich Ascites Carcinoma bearing mice
著者:: Islam, M. Saiful, 等
出版事項: (2016)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
著者:: Hossain, Safa Binte
出版事項: (2019)

Hypothesizing precise cancer treatments based on patient survival using machine learning & deep learning
著者:: Sakib, Hasibul, 等
出版事項: (2024)

Statistics and informatics in molecular cancer research

Immunotherapy in the treatment of renal cancer
著者:: Shimu, Sumaya
出版事項: (2022)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
著者:: Chowdhury, Maisha Mosharrat
出版事項: (2018)

Multidisciplinary Treatment of Hepatocellular Carcinoma
出版事項: (2013)

Diagnosis and treatment of non-alcoholic fatty liver disease
著者:: Haque, Sanjida
出版事項: (2020)

Cancer risk factors: a critical review
著者:: Tabassum, Tahsina
出版事項: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
著者:: Nawar, Anika
出版事項: (2019)

A systematic review on the comparison of the safety and efficacy of temozolomide and radiotherapy along with another drug combination in the treatment of glioblastoma multiforme
著者:: Chowdhury, Shamima Zerin
出版事項: (2022)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
著者:: Zangmo, Thinley
出版事項: (2024)

Targeting BRAFV600E in the treatment of CRC
著者:: Roja, Mashwiyat Samrin
出版事項: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Flora, Sanzida Alam
出版事項: (2024)

Role of statins as antagonists of SPARC in gastric cancer
著者:: Shahmat, Rad
出版事項: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
著者:: Pial, Sazia Afrin
出版事項: (2018)

A systematic review on the efficacy of Fluoxetine in the management of anxiety disorders
著者:: Akter, Rabia
出版事項: (2024)

Changing global policy to deliver safe, equitable, and affordable care for women's cancers
著者:: Ginsburg, Ophira M., 等
出版事項: (2018)

Epigenetic therapy in cancer
著者:: Abid, Md. Shadman Ridwan
出版事項: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
著者:: Khondokar, Faiza
出版事項: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
著者:: Mukti, Roushney Fatima, 等
出版事項: (2016)

RIPK pathway, as a potential target, for cancer treatment - a review
著者:: Jahan, Nusrat
出版事項: (2024)

Biosimilar in lymphoma treatment
著者:: Tanisha, Mehrin Haque
出版事項: (2021)